STING1 and ovarian carcinoma: Further highlighting the potential importance of RIGI and MDA5 in ovarian cancer, de Queiroz (66) found that cGAS-STING activation, but not that of MDA5 or RIGI, was impaired in a majority of ovarian cancer cell lines.